Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Central Proteina Prima Tbk. (CPRO) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Central Proteina Prima Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Central Proteina Prima Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Central Proteina Prima Tbk. trades at Rp50 (market cap 2.98T, 2.22M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Central Proteina Prima Tbk. is far larger — about 5.1× UBC Medical Indonesia Tbk.'s market cap, and Central Proteina Prima Tbk. is more actively traded (2.22M versus 817.3K). Which is the better fit depends on your goals.

CPROLABS
Market Cap
2.98T584.6B
Volume
2.22M817.3K
Lot
22.16K8.17K
Turnover
110.81M120.01M
Average Price
50146.84
Value
110.81M120.01M
Indicative Equilibrium Price
50146
Indicative Equilibrium Volume
3259

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CPRO
View details
LABS
View details

About Central Proteina Prima Tbk.

PT Central Proteinprima Tbk (The Company) was established on April 30, 1980 based on the Domestic Capital Investment Law No. 6 year 1968. Base on notarial deed no. 45 dated Dec 7, 1989 the company's share holders agreed offering 1.000.000 share to public, increase paid up capital and authorized capital. At 14 May 1990, the company's shares were treadeable in Jakarta Stock Exchange.Base on notarial deed no.7 dated 4 Oct 2004 of Fahiah Helmi, SH, the company was changed to private company. At Nov 5, 2004, base on JSX letter no S-1671/BEJ-PSR/11-2004 the company was delisted. And then at Sep 2004, the Company's ownership was changed to foreign investment. The Company’s articles of association has been amended several times, most recently by notarial deed No. 57 of Lies Herminingsih, S.H., dated Sep 30, 2006, concerning change of director's job description.

Read more on CPRO

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS